2009—2011年十堰市太和医院质子泵抑制剂应用分析  

Utilization of Proton Pump Inhibitors(PPI) in Shiyan Municipal Taihe Hospital During 2009-2011

作　　者：吕明[1] 王正军[1] 马朝晖[1] 

机构地区：[1]湖北医药学院附属太和医院药学部,湖北十堰442000

出　　处：《中国医院用药评价与分析》2012年第11期973-975,共3页Evaluation and Analysis of Drug-use in Hospitals of China

摘　　要：目的:了解我院质子泵抑制剂(PPI)的应用情况,为临床合理用药提供参考。方法:采用限定日剂量(DDD)法对2009—2011年我院PPI的销售金额、用药频度(DDDs)等进行统计分析。结果:我院PPI的总销售金额及总DDDs呈逐年增长趋势;销售金额及DDDs排序居前3位的药品分别为奥美拉唑、泮托拉唑、雷贝拉唑;口服PPI的DDDs构成比较高,应用较多;注射用PPI的销售金额构成比及DDDs构成比均逐年增加,应用增长较快。结论:我院PPI应用广泛,总体呈上升趋势,用药情况较合理。OBJECTIVE：To investigate the utilization of proton pump inhibitors（PPI） in our hospital so as to provide reference for rational use of PPI.METHODS：The defined daily dose（DDD） analysis was performed on the consumption sum and DDDs of PPI in our hospital from 2009 to 2011.RESULTS：The total consumption sum and total DDDs of PPI in our hospital increased year by year.Omeprazole,pantoprazole and rabeprazole were the top three on the lists of consumption sum and DDDs.The oral PPI had high ratio in DDDs and which had high consumption;however,the PPI for injection had year-on-year increase proportion in consumption sum and DDDs.CONCLUSION：PPI was widely used in our hospital showing an overall increase tendency and its use was rational on the whole.

关 键 词：质子泵抑制剂 销售金额 限定日剂量 用药频度 

分 类 号：R975[医药卫生—药品]